Stephen Villano
No más puestos en curso
Perfil
Stephen Villano worked as Vice President of Clinical Research & Development at Shire ViroPharma, Inc. and as Vice President of Clinical & Medical Affairs at Paratek Pharmaceuticals, Inc. He holds a doctorate degree from The Johns Hopkins University.
Antiguos cargos conocidos de Stephen Villano.
| Empresas | Cargo | Fin |
|---|---|---|
| PARATEK PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Corporate Officer/Principal | - |
Formación de Stephen Villano.
| The Johns Hopkins University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PARATEK PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Stephen Villano
